{"id":56584,"date":"2023-05-24T12:05:35","date_gmt":"2023-05-24T02:05:35","guid":{"rendered":"https:\/\/hudsonorgau.wpengine.com\/?post_type=hdsn_news_post&p=56584"},"modified":"2024-05-14T14:15:13","modified_gmt":"2024-05-14T04:15:13","slug":"cureator-funds-hudson-institute-biotech-innovation","status":"publish","type":"hdsn_news_post","link":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/","title":{"rendered":"CUREator funds Hudson Institute biotech innovation"},"content":{"rendered":"\n

Exciting new therapies for regenerative medicine as well as a targeted treatment for ovarian cancer<\/a> have been awarded significant funding from Australia\u2019s national biotechnology incubator, CUREator.<\/p>\n\n\n

\n
\"Professor
Professor Elizabeth Hartland<\/em><\/figcaption><\/figure>\n<\/div>\n\n\n

The grants are delivered by Brandon BioCatalyst and the Medical Research Future Fund (MRFF) to support early-stage health and medical research and innovation in Australia through to proof-of-concept and beyond, providing opportunities for commercialisation.<\/p>\n\n\n\n

Director and CEO of Hudson Institute of Medical Research, Professor Elizabeth Hartland<\/a>, called it wonderful recognition for two of the many great projects being developed at Hudson Institute.<\/p>\n\n\n\n

\u201cBoth of these projects show huge potential, not just from a scientific perspective, but as real-world treatments that will make a genuine difference, potentially to millions of people worldwide.\u201d Prof Hartland said.<\/p>\n\n\n\n

<\/p>\n\n\n\n

CUREator funds exosome therapies<\/h2>\n\n\n
\n
\"Associate
Associate Professor Rebecca Lim<\/em> <\/figcaption><\/figure>\n<\/div>\n\n\n

$1.5 million has been awarded to Exosome Bioscience, a collaboration between Hudson Institute and Monash University, utilising a unique platform technology to produce novel exosome therapies.<\/p>\n\n\n\n

$500,000 in pre-clinical funding was also awarded to biotechnology company AMTBio Pty Ltd, a joint venture with Hudson Institute, to bring its breakthrough treatment for ovarian cancer<\/a> to Phase I clinical trials.<\/p>\n\n\n\n

Associate Professor Rebecca Lim<\/a> from Hudson Institute and Exosome Bioscience, explained that exosomes are a class of nanosized vesicles released by all cell types, including stem cells. \u201cThey contain complex biological materials that reflect the intracellular contents of their donor cells.\u201d she said.<\/p>\n\n\n\n

<\/div>\n\n\n\n

The vesicles released by the human amniotic epithelial cells have been shown to be highly effective in pre-clinical models over a range of unmet clinical needs including lung, liver and kidney fibrosis.<\/p>\n\n\n

\n
\"Dr
L-R: Dr Maree Bilandzic, Dr Andrew Stephens, Ovarian Cancer Biomarkers Research group<\/em><\/figcaption><\/figure>\n<\/div>\n\n\n

“This funding will allow us to take these into a first-in-human clinical trial,” she said.<\/p>\n\n\n\n

Ovarian cancer trial – biotech innovation<\/h2>\n\n\n\n

Research Group Head, Ovarian Cancer Biomarkers at Hudson Institute and AMTBio Chief Executive Officer, Dr Andrew Stephens<\/a>, said, \u201cOur technology offers a new way to treat ovarian cancers, by directly targeting chemo-resistant cancer cells \u2013 one of the most pressing clinical issues in the effective management of patients\u201d.<\/p>\n\n\n\n

\u201cAMTBio was recognised by the CUREator program as having high potential to develop and bring this first-in-class treatment for ovarian cancer into clinical trials\u201d.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"CUREator<\/figure>
\n

About CUREator.  <\/em><\/strong>CUREator is a national biotechnology incubator run by Brandon BioCatalyst to support the development of Australian biomedical research and innovations.<\/em><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

Exciting new treatments for unmet medical needs including ovarian cancer have been awarded significant funding from Australia\u2019s national biotechnology incubator, CUREator.…  Read more<\/a><\/p>\n","protected":false},"featured_media":56586,"menu_order":0,"template":"","issue":[],"tag":[],"story-type":[87,86],"treatment-type":[92],"class_list":["post-56584","hdsn_news_post","type-hdsn_news_post","status-publish","has-post-thumbnail","hentry","story-type-award","story-type-industry","treatment-type-cell-therapies"],"acf":[],"yoast_head":"\nCUREator funds Melbourne biotech innovation | Hudson Institute<\/title>\n<meta name=\"description\" content=\"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CUREator funds Hudson Institute biotech innovation\" \/>\n<meta property=\"og:description\" content=\"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Hudson Institute of Medical Research\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-14T04:15:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/05\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/\",\"name\":\"CUREator funds Melbourne biotech innovation | Hudson Institute\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg\",\"datePublished\":\"2023-05-24T02:05:35+00:00\",\"dateModified\":\"2024-05-14T04:15:13+00:00\",\"description\":\"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg\",\"width\":600,\"height\":600,\"caption\":\"Dr Andrew Stephens, Dr Maree Bilandzic, Adjunct Associate Professor Rebecca Lim at Hudson Institute\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/cureator-funds-hudson-institute-biotech-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CUREator funds Hudson Institute biotech innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"name\":\"Hudson Institute of Medical Research\",\"description\":\"Transforming lives through scientific discovery.\",\"publisher\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hudson.org.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\",\"name\":\"Hudson Institute of Medical Research\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"width\":1200,\"height\":316,\"caption\":\"Hudson Institute of Medical Research\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CUREator funds Melbourne biotech innovation | Hudson Institute","description":"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/","og_locale":"en_US","og_type":"article","og_title":"CUREator funds Hudson Institute biotech innovation","og_description":"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.","og_url":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/","og_site_name":"Hudson Institute of Medical Research","article_modified_time":"2024-05-14T04:15:13+00:00","og_image":[{"width":600,"height":600,"url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/05\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/","url":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/","name":"CUREator funds Melbourne biotech innovation | Hudson Institute","isPartOf":{"@id":"https:\/\/hudson.org.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/#primaryimage"},"image":{"@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/05\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg","datePublished":"2023-05-24T02:05:35+00:00","dateModified":"2024-05-14T04:15:13+00:00","description":"Australia\u2019s national biotech incubator, CUREator, has funded two Hudson Institute projects with the potential to help millions worldwide.","breadcrumb":{"@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/#primaryimage","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/05\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2023\/05\/Andrw-Stephens-Maree-Bilandzic-Rebecca-Lim-e1684723603244.jpg","width":600,"height":600,"caption":"Dr Andrew Stephens, Dr Maree Bilandzic, Adjunct Associate Professor Rebecca Lim at Hudson Institute"},{"@type":"BreadcrumbList","@id":"https:\/\/hudson.org.au\/news\/cureator-funds-hudson-institute-biotech-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hudson.org.au\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/hudson.org.au\/news\/"},{"@type":"ListItem","position":3,"name":"CUREator funds Hudson Institute biotech innovation"}]},{"@type":"WebSite","@id":"https:\/\/hudson.org.au\/#website","url":"https:\/\/hudson.org.au\/","name":"Hudson Institute of Medical Research","description":"Transforming lives through scientific discovery.","publisher":{"@id":"https:\/\/hudson.org.au\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hudson.org.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/hudson.org.au\/#organization","name":"Hudson Institute of Medical Research","url":"https:\/\/hudson.org.au\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","width":1200,"height":316,"caption":"Hudson Institute of Medical Research"},"image":{"@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/56584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post"}],"about":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/types\/hdsn_news_post"}],"version-history":[{"count":0,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/56584\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media\/56586"}],"wp:attachment":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media?parent=56584"}],"wp:term":[{"taxonomy":"issue","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/issue?post=56584"},{"taxonomy":"tag","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/tag?post=56584"},{"taxonomy":"story-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/story-type?post=56584"},{"taxonomy":"treatment-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/treatment-type?post=56584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}